Cart summary

You have no items in your shopping cart.

Sulfatinib

SKU: orb1303189

Description

Sulfatinib (KDR-IN-1, HMPL-012) is a highly selective small molecule inhibitor targeting VEGFR1/2/3, FGFR1, and CSF1R with potent activity in the low nanomolar range. It is a valuable research tool for investigating angiogenesis, tumor microenvironment, and related signaling pathways in both cellular and animal models of cancer and inflammatory diseases.

Research Area

Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number1308672-74-3
MW480.58
Purity>99.99% (May vary between batches)
FormulaC24H28N6O3S
SMILESCN(C)CCNS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4[nH]c(C)cc4c3)n2)c1
TargetFGFR,VEGFR,Potassium Channel
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.16 mM);DMSO:55 mg/mL (114.45 mM)

Bioactivity

In Vivo
In animal studies, a single oral dose of Sulfatinib effectively inhibits VEGFR2 phosphorylation stimulated by VEGF in lung tissues of nude mice in an exposure-dependent manner. Additionally, a rise in FGF23 plasma levels 24 hours after dosing indicates a suppression of FGFR signaling. Sulfatinib exhibits strong antitumor efficacy across various human xenograft models and significantly reduces CD31 expression, which evidences its potent antiangiogenic effects via the inhibition of VEGFR and FGFR signaling pathways. In the CT-26 syngeneic murine colon cancer model, Sulfatinib achieves moderate tumor growth inhibition following monotherapy. Moreover, after a 10 mg/kg oral dose, the AUC and C_max in mice are 397 ng/mL and 138 ng/mL, respectively .
In Vitro
Sulfatinib inhibits VEGFR1, 2, and 3, FGFR1 and CSF1R kinases with IC 50 s in a range of 1 to 24 nM. Sulfatinib strongly blocks VEGF induced VEGFR2 phosphorylation in HEK293KDR cells and CSF1 stimulated CSF1R phosphorylation in RAW264.7 cells with IC 50 of 2 and 79 nM, respectively. Sulfatinib also attenuates VEGF or FGF stimulated HUVEC cells proliferation with IC 50 < 50 nM . Also, it is a hERG inhibitor with IC 50 of 6.8 μM in CHO cell .

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

KDR-IN-1, KDR, FGFR1, hERG, Sulfatinib

Similar Products

  • Sulfatinib [orb1223225]

    >98% (HPLC)

    1816307-67-1

    480.6

    C24H28N6O3S

    25 mg, 1 g, 500 mg, 200 mg, 100 mg, 2 mg, 5 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Sulfatinib (orb1303189)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 80.00
1 ml x 10 mM (in DMSO)
$ 120.00
5 mg
$ 120.00
10 mg
$ 140.00
25 mg
$ 200.00
50 mg
$ 280.00
100 mg
$ 420.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry